Heart surgery bleeding breakthrough? new study tests Desmopressin's Clot-Boosting power
NCT ID NCT07179991
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at how desmopressin, a drug that helps blood clot, affects platelet function in 100 adults undergoing heart surgery with a heart-lung machine. Researchers will use a special blood test called TEG6s to measure clotting at several time points before and after giving desmopressin. The goal is to better understand how the drug works and whether it can reduce the need for blood transfusions after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Desmopressin (DDAVP)
What this could lead to
If successful, this could help doctors better understand how desmopressin improves clotting, potentially reducing blood transfusions in heart surgery patients.
What could go wrong
This is a small, early-stage observational study focused on measuring effects, not proving clinical outcomes. Results may not change current practice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRAOPERATIVE BLEEDING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••